ArchiMed, an investment firm focused exclusively on the healthcare industry, completed the acquisition of Natus Medical, a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services, for $1.2bn. “The sale of Natus to ArchiMed will provide our shareholders with immediate and substantial cash value, as well as a compelling premium, and the Board has unanimously agreed that this transaction is in the best interests of our shareholders,” Joshua H. Levine, Natus Chairman.